Brief: Spectrum Pharma Reports Q2 NON-GAAP Loss Per Share Of $0.25
12/08/2021 23:15
Aug 12 (Reuters) - Spectrum Pharmaceuticals Inc SPPI.O :
* SPECTRUM PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND CORPORATE UPDATE
* Q2 NON-GAAP LOSS PER SHARE $0.25
* Q2 LOSS PER SHARE $0.32
* Q2 EARNINGS PER SHARE ESTIMATE $-0.26 -- REFINITIV IBES
DATA
* SPECTRUM PHARMACEUTICALS - ENDED QUARTER WITH CASH,
EQUIVALENTS,
AND MARKETABLE SECURITIES OF $158.8 MILLION
Source text for Eikon: ID:nBw1jh39ga
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary